Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
26.7M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$134M
-
Value change
-
-$7.69M
-
Put/Call ratio
-
0.14
-
Number of buys
-
33
-
Number of sells
-
-40
-
Price
-
$5.02
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q1 2024
94 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q1 2024.
scPharmaceuticals Inc. - Common Stock (SCPH) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.7M shares
of 53.4M outstanding shares and own 50.1% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.56M shares), Rubric Capital Management LP (3.53M shares), AIGH Capital Management LLC (3.39M shares), BlackRock Inc. (1.8M shares), KING LUTHER CAPITAL MANAGEMENT CORP (1.45M shares), VANGUARD GROUP INC (1.37M shares), 5AM Venture Management, LLC (1.2M shares), J. Goldman & Co LP (1.12M shares), Thrivent Financial for Lutherans (1.07M shares), and Tejara Capital Ltd (698K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.